Suppr超能文献

水飞蓟黄酮木脂素葡萄糖醛酸苷的化学酶法合成、表征及放大研究

Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides.

作者信息

Gufford Brandon T, Graf Tyler N, Paguigan Noemi D, Oberlies Nicholas H, Paine Mary F

机构信息

Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Spokane, Washington (B.T.G., M.F.P.); and Department of Chemistry and Biochemistry, The University of North Carolina at Greensboro, Greensboro, North Carolina (T.N.G., N.D.P., N.H.O.).

Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Spokane, Washington (B.T.G., M.F.P.); and Department of Chemistry and Biochemistry, The University of North Carolina at Greensboro, Greensboro, North Carolina (T.N.G., N.D.P., N.H.O.)

出版信息

Drug Metab Dispos. 2015 Nov;43(11):1734-43. doi: 10.1124/dmd.115.066076. Epub 2015 Aug 27.

Abstract

Plant-based therapeutics, including herbal products, continue to represent a growing facet of the contemporary health care market. Mechanistic descriptions of the pharmacokinetics and pharmacodynamics of constituents composing these products remain nascent, particularly for metabolites produced following herbal product ingestion. Generation and characterization of authentic metabolite standards are essential to improve the quantitative mechanistic understanding of herbal product disposition in both in vitro and in vivo systems. Using the model herbal product, milk thistle, the objective of this work was to biosynthesize multimilligram quantities of glucuronides of select constituents (flavonolignans) to fill multiple knowledge gaps in the understanding of herbal product disposition and action. A partnership between clinical pharmacology and natural products chemistry expertise was leveraged to optimize reaction conditions for efficient glucuronide formation and evaluate alternate enzyme and reagent sources to improve cost effectiveness. Optimized reaction conditions used at least one-fourth the amount of microsomal protein (from bovine liver) and cofactor (UDP glucuronic acid) compared with typical conditions using human-derived subcellular fractions, providing substantial cost savings. Glucuronidation was flavonolignan-dependent. Silybin A, silybin B, isosilybin A, and isosilybin B generated five, four, four, and three monoglucuronides, respectively. Large-scale synthesis (40 mg of starting material) generated three glucuronides of silybin A: silybin A-7-O-β-D-glucuronide (15.7 mg), silybin A-5-O-β-D-glucuronide (1.6 mg), and silybin A-4´´-O-β-D-glucuronide (11.1 mg). This optimized, cost-efficient method lays the foundation for a systematic approach to synthesize and characterize herbal product constituent glucuronides, enabling an improved understanding of mechanisms underlying herbal product disposition and action.

摘要

包括草药产品在内的植物性疗法,在当代医疗保健市场中所占份额持续增长。对构成这些产品的成分的药代动力学和药效学的机制描述仍处于起步阶段,尤其是草药产品摄入后产生的代谢物。生成并表征真实的代谢物标准品对于提高对体外和体内系统中草药产品处置的定量机制理解至关重要。以模型草药产品水飞蓟宾为例,这项工作的目标是生物合成多毫克量的选定成分(黄酮木脂素)的葡萄糖醛酸苷,以填补在理解草药产品处置和作用方面的多个知识空白。利用临床药理学和天然产物化学专业知识之间的合作关系,优化反应条件以实现高效的葡萄糖醛酸苷形成,并评估替代酶和试剂来源以提高成本效益。与使用人源亚细胞组分的典型条件相比,优化后的反应条件使用的微粒体蛋白(来自牛肝)和辅因子(UDP葡萄糖醛酸)量至少减少了四分之三,从而大幅节省了成本。葡萄糖醛酸化反应依赖于黄酮木脂素。水飞蓟宾A、水飞蓟宾B、异水飞蓟宾A和异水飞蓟宾B分别生成了5种、4种、4种和3种单葡萄糖醛酸苷。大规模合成(40毫克起始原料)生成了水飞蓟宾A的3种葡萄糖醛酸苷:水飞蓟宾A-7-O-β-D-葡萄糖醛酸苷(15.7毫克)、水飞蓟宾A-5-O-β-D-葡萄糖醛酸苷(1.6毫克)和水飞蓟宾A-4´´-O-β-D-葡萄糖醛酸苷(11.1毫克)。这种优化的、具有成本效益的方法为系统合成和表征草药产品成分葡萄糖醛酸苷奠定了基础,有助于更好地理解草药产品处置和作用的潜在机制。

相似文献

本文引用的文献

2
Addressing the challenges of low clearance in drug research.应对药物研究中低清除率的挑战。
AAPS J. 2015 Mar;17(2):352-7. doi: 10.1208/s12248-014-9691-7. Epub 2015 Jan 8.
7
Biotransformation of silybin and its congeners.水飞蓟宾及其同系物的生物转化。
Curr Drug Metab. 2013 Dec;14(10):1009-21. doi: 10.2174/1389200214666131118234507.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验